China vs Cuba: Treatment success rate for patients treated for MDR-TB
China
68.0%
in 2022
Cuba
67.0%
in 2022
China rank
104th
Cuba rank
106th
Treatment success rate for patients treated for MDR-TB over time
- China
- Cuba
How they compare
China currently reports 68.0% against 67.0% in Cuba, a difference of 1.0%.
The two have swapped places 9 times across 15 shared years of data; in 2008 it was Cuba ahead.
China ranks 104th and Cuba ranks 106th of 163 countries.
Across the 3 decades both report, China averaged higher in 1 and Cuba in 2.
Head to head by decade
| Decade | China | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.0% | 66.5% | 20.5% | Cuba |
| 2010s | 48.4% | 56.7% | 8.3% | Cuba |
| 2020s | 61.7% | 58.0% | 3.7% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, China or Cuba?
- China, at 68.0% against 67.0% in Cuba as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between China and Cuba?
- 1.0%, with China ahead.
- How many years of comparable data are there for China and Cuba?
- 15 years are reported by both, from 2008 to 2022.
- How do China and Cuba rank globally for treatment success rate for patients treated for mdr-tb?
- China ranks 104th and Cuba ranks 106th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.